intravitreal anti-vascular endothelial growth factor use in France during COVID-19 pandemic
This study quantified changes in the use of intravitreal (IVT) anti-vascular endothelial growth factors (anti-VEGF), the main treatment for retinal vascular abnormalities, since the COVID-19 pandemic started in France.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
More News: COVID-19 | France Health | International Medicine & Public Health | Pandemics | Science | Study | Vitamin A